Regeneron Pharmaceuticals (REGN) Dividends Paid - Common (2025 - 2026)

Regeneron Pharmaceuticals' (REGN) quarterly Dividends Paid - Common came in at $97.8 million in Q1 2026, up 4.26% year-on-year from $93.8 million in Q1 2025, and up 5.5% quarter-over-quarter from $92.7 million in Q4 2025.

Regeneron Pharmaceuticals (REGN) Dividends Paid - Common (2025 - 2026) Analysis & Trends

Regeneron Pharmaceuticals' Dividends Paid - Common history runs 2 years deep, the most recent figure standing at $97.8 million for Q1 2026.

  • On a quarterly basis, Dividends Paid - Common rose 4.26% year-over-year to $97.8 million in Q1 2026; TTM through Mar 2026 was $374.3 million, a 299.04% increase from a year earlier, with the FY2025 full-year figure at $370.3 million, changed N/A from the prior year.
  • Dividends Paid - Common grew to $97.8 million in Q1 2026 per REGN's latest filing, from $92.7 million in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $97.8 million in Q1 2026 and bottomed at $91.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 97.80 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 97.80 Mn
Mar 31, 2026 97.80 Mn
Dec 31, 2025 92.70 Mn
Dec 31, 2025 92.70 Mn
Sep 30, 2025 91.20 Mn
Sep 30, 2025 91.20 Mn
Jun 30, 2025 92.60 Mn
Jun 30, 2025 92.60 Mn
Mar 31, 2025 93.80 Mn
Mar 31, 2025 93.80 Mn